A comparative clinical study on the management of urticaria by the oral use of adraka khanda with or without nimbadi lepa

A comparative clinical study on the management of sheetapitta w.s.r to urticaria by the oral use of adraka khanda with or without nimbadi lepa - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/072289

Enrollment

Registered

2024-08-09

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L502- Urticaria due to cold and heat

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients having signs and symptoms of Sheetapitta with the feature erythematous , oedematous papules and plaque wheals

Exclusion criteria

Exclusion criteria: Unconscious & semiconscious patients,malignancy - in any organ,systemic diseases like uncontrolled hypertension & diabetes mellitus,tuberculosis, paralysis and parkinsonism etc.Hyperlipidaema, chronic renal failure,chronic liver disease, pregnant women,long term steroid dependant.

Design outcomes

Primary

Measure	Time frame
The oral use of adraka khanda with local application of nimbadi lepa may show improvement in symptoms like erythmatous,oedematous papules and plaque wheals,itching,burning sensationTimepoint: 0th,14th Day,28th Day,42th Day	—

Secondary

Measure	Time frame
The oral use of adraka khand with local application of nimbadi lepa may show improvement in objective parameter such as Ige,ESR,DC, TC testTimepoint: 0th,14th Day,28th day, 42th day	—

Countries

India

Contacts

Public ContactPRAKASH KUMAR NAIK

The West Bengal University of Health Sciences

naikpraksh323@gmail.com7894422358

Outcome results